JournalsHub
.online
Find My Journal
MS

Michael W. Schuster

Stony Brook University Hospital US

128
Publications
7,728
Citations
35
H-Index
64
i10-Index
4.0
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma OA
Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster, David Irwin, Edward A. Stadtmauer +16 more
New England Journal of Medicine 2005
2,489
Nutritional Recommendations for the Management of Sarcopenia OA
John E. Morley, Josep M. Argilés, William J. Evans, Shalender Bhasin, David Cella +17 more
Journal of the American Medical Directors Association 2010
652
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose‐modification guideline OA
Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster, Edward A. Stadtmauer, Thierry Façon +14 more
British Journal of Haematology 2009
307
Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials
Sundar Jagannath, Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster, David Irwin +5 more
Leukemia 2006
265
Analysis of Herpes Zoster Events Among Bortezomib-Treated Patients in the Phase III APEX Study OA
Asher Chanan‐Khan, Pieter Sonneveld, Michael W. Schuster, Edward A. Stadtmauer, Thierry Façon +8 more
Journal of Clinical Oncology 2008
265

Publications

128 total

Nutritional Recommendations for the Management of Sarcopenia PDF

John E. Morley, Josep M. Argilés, William J. Evans, Shalender Bhasin, David Cella et al. - Journal of the American Medical Directors Association, 2010
Cited by 652 OpenAlex

Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose‐modification guideline PDF

Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster, Edward A. Stadtmauer, Thierry Façon et al. - British Journal of Haematology, 2009
Cited by 307 OpenAlex

Analysis of Herpes Zoster Events Among Bortezomib-Treated Patients in the Phase III APEX Study PDF

Asher Chanan‐Khan, Pieter Sonneveld, Michael W. Schuster, Edward A. Stadtmauer, Thierry Façon et al. - Journal of Clinical Oncology, 2008
Cited by 265 OpenAlex

Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study

Jesús F. San Miguel, Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster, David Irwin et al. - Leukemia, 2008
Cited by 184 OpenAlex

Stem Cell Mobilization with Cyclophosphamide Overcomes the Suppressive Effect of Lenalidomide Therapy on Stem Cell Collection in Multiple Myeloma PDF

Tomer M. Mark, Jessica Stern, Jessica Furst, David Jayabalan, Faiza Zafar et al. - Biology of Blood and Marrow Transplantation, 2008
Cited by 116 OpenAlex

BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma. PDF

Rubén Niesvizky, David Jayabalan, Paul J. Christos, Jessica Furst, Tara Naib et al. - Blood, 2007
Cited by 183 OpenAlex

Safety and efficacy of bortezomib in high‐risk and elderly patients with relapsed multiple myeloma

Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster, David Irwin, Edward A. Stadtmauer et al. - British Journal of Haematology, 2007
Cited by 126 OpenAlex

Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials

Sundar Jagannath, Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster, David Irwin et al. - Leukemia, 2006
Cited by 265 OpenAlex

Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma PDF

Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster, David Irwin, Edward A. Stadtmauer et al. - New England Journal of Medicine, 2005
Cited by 2,489 OpenAlex

Abbreviated Chemotherapy With Fludarabine Followed by Tositumomab and Iodine I 131 Tositumomab for Untreated Follicular Lymphoma PDF

John P. Leonard, Morton Coleman, Lale Kostakoğlu, Amy Chadburn, Ethel Cesarman et al. - Journal of Clinical Oncology, 2005
Cited by 158 OpenAlex

Research Topics

Multiple Myeloma Research and Treatments (32) Acute Myeloid Leukemia Research (21) Hematopoietic Stem Cell Transplantation (19) Nutrition and Health in Aging (14) Protein Degradation and Inhibitors (13)

Frequent Co-Authors

PA
Paul G. Richardson
6 joint publications
PI
Pieter Sonneveld
6 joint publications
TH
Thierry Façon
6 joint publications
ED
Edward A. Stadtmauer
5 joint publications
DI
Dina Ben‐Yehuda
5 joint publications
SA
Sagar Lonial
5 joint publications

Affiliations

Kagoshima University
JP 2006 - 2006
Atrium Health Wake Forest Baptist
US 2006 - 2006
Northwell Health
US 1996 - 1996
NewYork–Presbyterian Hospital
US 2010 - 1999
Harvard University
US 1985 - 1985

External Profiles

OpenAlex Profile Search Semantic Scholar Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now